Mhr Fund Management LLC Iovance Biotherapeutics, Inc. Transaction History
Mhr Fund Management LLC
- $752 Million
- Q4 2024
A detailed history of Mhr Fund Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mhr Fund Management LLC holds 24,417,103 shares of IOVA stock, worth $136 Million. This represents 24.02% of its overall portfolio holdings.
Number of Shares
24,417,103
Previous 23,997,103
1.75%
Holding current value
$136 Million
Previous $225 Million
19.81%
% of portfolio
24.02%
Previous 28.52%
Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
339Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$153 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$123 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$68.1 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL8.99MShares$50 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $877M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...